首頁LGND • NASDAQ
add
Ligand Pharmaceuticals Inc
前次收盤價
$86.12
單日股價範圍
$84.05 - $87.33
一年股價範圍
$49.24 - $94.57
總市值
15.68億 USD
平均交易量
16.87萬
本益比
16.68
股利收益率
-
主要交易所
NASDAQ
財務資料
損益表
收益
淨利
| (USD) | 2023年12月info | 逐年變化幅度 |
|---|---|---|
收益 | 2810.10萬 | -44.22% |
營業費用 | 2433.00萬 | -38.67% |
淨利 | 1818.80萬 | 204.02% |
淨利潤率 | 64.72 | 286.51% |
每股盈餘 | 1.38 | 1.47% |
營業資金流動 | 556.30萬 | 162.05% |
有效稅率 | -6.38% | — |
資產負債表
總資產
總負債
| (USD) | 2023年12月info | 逐年變化幅度 |
|---|---|---|
現金和短期投資 | 1.70億 | -19.62% |
總資產 | 7.87億 | 3.22% |
總負債 | 8630.30萬 | -47.75% |
總權益 | 7.01億 | — |
流通股份 | 1770.53萬 | — |
股價淨值比 | 2.16 | — |
資產報酬率 | -1.08% | — |
資本報酬率 | -1.22% | — |
現金流量
現金變動淨額
| (USD) | 2023年12月info | 逐年變化幅度 |
|---|---|---|
淨利 | 1818.80萬 | 204.02% |
營運現金 | 806.50萬 | -84.92% |
投資現金 | -1028.40萬 | -41.19% |
融資現金 | 531.50萬 | 200.32% |
現金變動淨額 | 309.60萬 | -92.43% |
自由現金流 | -4011.56萬 | -235.29% |
簡介
Ligand Pharmaceuticals is a biopharmaceutical company located in San Diego, California. Founded in 1987 as Progenix Inc., the company went public in 1992. Initially focused on developing its own drugs, a period of turbulence in the early 2000s culminated in its CEO being ejected by the shareholders and provoked a change in focus to the acquisition of existing drugs and forming partnerships to develop them further.
The company has been the subject of multiple regulatory investigations, negative shorts-seller reports and class action lawsuits amid allegations of securities fraud.
In 2018 its CEO was listed among the top five highest paid CEOs in San Diego. Wikipedia
成立時間
9月 1987
員工數
58
